This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering



MecoxCureMed Co., Ltd. is a pharmaceutical company dedicated to the discovery, development and commercialization of the cutting-edge drugs to treat cancers and related diseases. We are company headquartered in Seongnam, Korea with 3 associated laboratories which focused on drug delivery system (DDS), fermenting cytotoxic substance and medical chemistry. The company was founded in 2006 as Contract Research Organization and committed to achieving new drug development function through participating various development projects through over decade until now. Mecox has been practice with open innovated pharmaceutical value and vision through platform base drug development which may easily adopt proven technique and new & generic substances into Mecox’s platform of drug delivery system (DDS) to achieve faster availability for patient centered healthcare service network. Mecox is working on visions, our business consistent with all applicable regulation and quality, pursuing pharmaceutical open innovation to deliver high standard business results, and maintaining a business environment with mutual respect, openness and integrity. Core scientific expert groups are working inside such as physician, pharmacist, biologist, chemist, and lab technician, as well as external expert groups to achieve open innovation. Key personnel members including founder are more than 10-15 years of multinational and domestic pharmaceutical experience in essential research and development field, all of colleagues are working different locations, head office and 3 different laboratories.